Investor Trust and Market Timing Shape the New IPO Playbook
From left to right: Kimberly Ha, HHA Advisors; Andrew Lam, Ally Bridge Group; Jakob Dupont, Sofinnova Investments; Chirag Surti, Morgan Stanley; Jennifer Fang, Wilson Sonsini; & Jordan Saxe, NASDAQ. Image source: GeneOnline
At the 2025 BIO International Convention, the panel “Preparing for an IPO: Best Practices for Success” brought together leaders from across the biotech investment and advisory landscape to share practical guidance for companies eyeing the public markets. Speakers included Jakob Dupont, Executive Partner at Sofinnova Investments; Jennifer Fang, Partner at Wilson Sonsini; Andrew Lam, Managing … Investor Trust and Market Timing Shape the New IPO Playbook Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




